Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 20.04.2026 FEUZ IE00B8X9NY41 1,677,463.00 EUR 105,327,684.31 62.790  ...
-

BST Global Opens Registration for Third Annual AI Summit, November 10–12, 2026, Palm Beach, FL

TAMPA, Fla.--(BUSINESS WIRE)--BST Global opens registration for its AI Summit, November 10–12, 2026, in Palm Beach, for AEC executives exploring AI and data....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 20.04.2026 FEUD IE00BF2FL590 367,749.00 EUR 20,455,492.12 55.624  ...
-

Katch Named Premier Sponsor of 2026 AI Summit

ATLANTA--(BUSINESS WIRE)--The AI for Payment Integrity Community today announced that Katch, a leader in payment coordination and subrogation, will serve as the premier, Diamond Sponsor of the 2026 AI Summit, taking place October 6-7 in Atlanta. The Summit brings together nearly 100 senior executives from across payers, healthcare agencies, and PBMs around a shift already taking hold across the industry: moving from downstream payment recovery to earlier, more proactive intervention powered by...
-

SAM Announces Successful Deployment of CIM-Based Network Model Management Program for Ameren

AUSTIN, Texas--(BUSINESS WIRE)--Xtensible, a SAM company, today announced the successful production deployment of the next phase of Ameren’s CIM-based Grid Network Model Management (GNMM) program supporting sub-transmission and distribution systems. Xtensible led the design, implementation, and system integration of a production-grade CIM network model that now publishes directly to Ameren’s Advanced Distribution Management System (ADMS) and its distribution planning platform, Synergi Electric,...
-

AHF Launches Statewide Campaign Urging Full Restoration of Florida's AIDS Drug Assistance Program

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AHF Launches Statewide Campaign Urging Full Restoration of Florida's AIDS Drug Assistance Program...
-

KBRA Releases Research – Implications for Global Shipping

NEW YORK--(BUSINESS WIRE)--This KBRA report explores the potential credit implications of the conflict involving Iran for the shipping sector, including near-term effects and the impact of a prolonged disruption. The conflict has become a broad shock to shipping, impairing flows through the Strait of Hormuz—one of the world’s key energy chokepoints—while reinforcing a broader operating environment of rerouting, insurance repricing, and network inefficiency. The most immediate effects on shippin...
-

Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced an oral presentation and multiple poster presentations across five abstracts at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting, taking place May 29–June 2 in Chicago. Presentation Details: Title: Interim analysis results from...
-

Vertical Cold Storage Facilities Approved to Store CME Spot Call Butter

KANSAS CITY, Mo.--(BUSINESS WIRE)--Vertical Cold Storage announced today that five of its facilities have received official approval from CME Group to store its Spot Call Butter...
-

Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced that data from RINGSIDE, its global, Phase 3, randomized, placebo-controlled trial of varegacestat in patients with progressing desmoid tumors, has been selected for presentation in an oral abstract session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 2...